|
Redwood City, CA – February 15, 2008
Genesis Medical Interventional, Inc. was profiled in Windhover Information, Inc.'s January 2008 edition of Start-Up: Emerging Medical Ventures magazine. The article presents an overview of the company, its senior staff and a history of the technology used in Genesis' products. The author clearly and concisely explains how the FAST™ Funnel Catheter™ works and why it is preferable to competitor devices. CEO, Will Dubrul says, "We are honored to be included as one of Start-Up magazine's up and coming companies."
About Genesis Medical Interventional, Inc.
Genesis Medical Interventional, Inc. (Genesis) is a privately held company developing products, based on its minimally invasive Funnel Catheter platform technologies, to remove thrombi and emboli from the vasculature. The company believes its technologies will have applications in many major medical markets. The F.A.S.T. Funnel Catheter has been cleared by the FDA via 510(k) marketing clearance and has a proven track record with over 100 peripheral and coronary clinical cases completed with excellent results.
For additional information, please contact William R. Dubrul, Genesis CEO at will@genesismedical.net or visit the Genesis website at www.genesismedical.net .
This press release contains forward-looking statements that are based upon management's current expectations and are inherently uncertain. Forward-looking statements are based upon information available to us as of the date of this press release and we assume no obligation to revise or update any such forward-looking statement to reflect any event or circumstance after the date of this release. Actual results and timing of events could differ materially from current expectations and from any forward-looking statements made by the company.
|
